Affiliated Fund
Daily price w/o sales charge as of 01/21/2022
$17.68
$0.22
YTD Returns w/o sales charge as of 01/21/2022
-5.71%
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 12/31/2021
- Total Net Assets
- $6.68 B
- Inception Date
- 04/05/2017
- Dividend Frequency
- Quarterly
- Fund Expense Ratio
- 0.38%
- Number of Holdings
- 65
Yield
12-Month Dividend Yield 1 as of 01/21/2022
| w/o sales charge | 1.78% |
30-Day Standardized Yield 2 as of 12/31/2021
| 1.56% |
In absence of the fee waiver, yields shown would have been lower. Yields for other share classes will vary.
Fund Expense Ratio :
0.38%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception |
|---|
| w/o sales charge | 27.12% | 27.12% | 16.53% | 11.35% | 12.91% | - |
| Lipper Category Avg. Equity Income Funds | 25.00% | 25.00% | 17.76% | 11.86% | 11.91% | - |
| Russell 1000® Value Index | 25.16% | 25.16% | 17.64% | 11.16% | 12.97% | - |
Fund Expense Ratio :
0.38%
Fund Expense Ratio :
0.38%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception |
|---|
| w/o sales charge | 27.12% | 27.12% | 16.53% | 11.35% | 12.91% | - |
| Lipper Category Avg. Equity Income Funds | 25.00% | 25.00% | 17.76% | 11.86% | 11.91% | - |
| Russell 1000® Value Index | 25.16% | 25.16% | 17.64% | 11.16% | 12.97% | - |
Fund Expense Ratio :
0.38%
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
TEN LARGEST HOLDINGS as of 12/31/2021View Portfolio
| Holding | Assets |
|---|---|
| UnitedHealth Group Inc | 3.7% |
| NextEra Energy Inc | 3.3% |
| AbbVie Inc | 3.2% |
| Morgan Stanley | 3.2% |
| JPMorgan Chase & Co | 2.9% |
| Microsoft Corp | 2.7% |
| Pfizer Inc | 2.7% |
| Marathon Petroleum Corp | 2.6% |
| Danaher Corp | 2.5% |
| Ameriprise Financial Inc | 2.4% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 12/31/2021View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
12-Month Dividend Yield 1 as of 01/21/2022
| w/o sales charge | 1.78% |
30-Day Standardized Yield 2 as of 12/31/2021
| Subsidized3 | Un-Subsidized4 | |
|---|---|---|
| w/o sales charge | 1.56% | 1.56% |
In absence of the fee waiver, yields shown would have been lower. Yields for other share classes will vary.
Fund Expense Ratio :
0.38%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception |
|---|
| w/o sales charge | 27.12% | 27.12% | 16.53% | 11.35% | 12.91% | - |
| Lipper Category Avg. Equity Income Funds | 25.00% | 25.00% | 17.76% | 11.86% | 11.91% | - |
| Russell 1000® Value Index | 25.16% | 25.16% | 17.64% | 11.16% | 12.97% | - |
Fund Expense Ratio :
0.38%
Fund Expense Ratio :
0.38%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception |
|---|
| w/o sales charge | 27.12% | 27.12% | 16.53% | 11.35% | 12.91% | - |
| Lipper Category Avg. Equity Income Funds | 25.00% | 25.00% | 17.76% | 11.86% | 11.91% | - |
| Russell 1000® Value Index | 25.16% | 25.16% | 17.64% | 11.16% | 12.97% | - |
Fund Expense Ratio :
0.38%
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
| Year | Fund Returns | Russell 1000® Value Index |
|---|
| 2021 | 27.12% | 25.16% |
| 2020 | -0.95% | 2.80% |
| 2019 | 25.69% | 26.54% |
| 2018 | -7.09% | -8.27% |
| 2017 | 16.40% | 13.66% |
| 2016 | 17.83% | 17.34% |
| 2015 | -3.83% | -3.83% |
| 2014 | 12.34% | 13.45% |
| 2013 | 32.80% | 32.53% |
| 2012 | 16.36% | 17.51% |
| 2011 | -7.47% | - |
| 2010 | 14.87% | - |
| 2009 | 19.94% | - |
| 2008 | -36.87% | - |
| 2007 | 4.13% | - |
| 2006 | - | - |
| Year | Q1 | Q2 | Q3 | Q4 | Yearly Returns |
|---|
| 2022 | - | - | - | - | -5.71% |
| 2021 | 8.86% | 5.71% | -0.03% | 10.49% | 27.12% |
| 2020 | -27.86% | 15.61% | 5.43% | 12.64% | -0.95% |
| 2019 | 10.68% | 3.85% | 2.56% | 6.62% | 25.69% |
| 2018 | -2.30% | 0.57% | 6.63% | -11.32% | -7.09% |
| 2017 | 4.15% | 2.12% | 3.10% | 6.16% | 16.40% |
| 2016 | 2.59% | 3.28% | 3.83% | 7.10% | 17.83% |
| 2015 | 0.50% | -1.14% | -7.49% | 4.62% | -3.83% |
| 2014 | 2.30% | 4.13% | -0.02% | 5.49% | 12.34% |
| 2013 | 11.06% | 3.95% | 4.59% | 9.98% | 32.80% |
| 2012 | 12.69% | -4.57% | 6.69% | 1.41% | 16.36% |
| 2011 | 5.68% | -2.57% | -20.73% | 13.37% | -7.47% |
| 2010 | 6.89% | -14.30% | 10.44% | 13.55% | 14.87% |
| 2009 | -16.35% | 18.86% | 16.46% | 3.58% | 19.94% |
| 2008 | -9.60% | -5.95% | -6.59% | -20.51% | -36.87% |
| 2007 | 0.43% | 5.27% | 1.95% | -3.39% | 4.13% |
| 2006 | - | - | - | 5.52% | - |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
NAV HISTORICAL PRICES
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| UnitedHealth Group Inc | Health Care | 3.7% |
| NextEra Energy Inc | Utilities | 3.3% |
| AbbVie Inc | Health Care | 3.2% |
| Morgan Stanley | Financials | 3.2% |
| JPMorgan Chase & Co | Financials | 2.9% |
| Microsoft Corp | Information Technology | 2.7% |
| Pfizer Inc | Health Care | 2.7% |
| Marathon Petroleum Corp | Energy | 2.6% |
| Danaher Corp | Health Care | 2.5% |
| Ameriprise Financial Inc | Financials | 2.4% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Microsoft Corp | Information Technology | 3.8% |
| NextEra Energy Inc | Utilities | 3.3% |
| UnitedHealth Group Inc | Health Care | 3.2% |
| JPMorgan Chase & Co | Financials | 3.1% |
| Morgan Stanley | Financials | 3.0% |
| AbbVie Inc | Health Care | 2.6% |
| Danaher Corp | Health Care | 2.6% |
| Marathon Petroleum Corp | Energy | 2.5% |
| Ameriprise Financial Inc | Financials | 2.5% |
| Pfizer Inc | Health Care | 2.4% |
| Honeywell International Inc | Industrials | 2.1% |
| Prologis Inc | Real Estate | 2.1% |
| Chevron Corp | Energy | 2.1% |
| Home Depot Inc/The | Consumer Discretionary | 2.0% |
| Texas Instruments Inc | Information Technology | 2.0% |
| Northrop Grumman Corp | Industrials | 2.0% |
| Raytheon Technologies Corp | Industrials | 1.9% |
| Fidelity National Financial Inc | Financials | 1.8% |
| Dover Corp | Industrials | 1.8% |
| Union Pacific Corp | Industrials | 1.7% |
| American Financial Group Inc/OH | Financials | 1.7% |
| BlackRock, Inc. | Financials | 1.7% |
| KKR & Co Inc | Financials | 1.7% |
| Cboe Global Markets Inc | Financials | 1.7% |
| Western Alliance Bancorp | Financials | 1.7% |
| Royal Dutch Shell PLC | Energy | 1.7% |
| Lowe's Cos Inc | Consumer Discretionary | 1.7% |
| Bank of America Corp | Financials | 1.7% |
| Avery Dennison Corp | Materials | 1.6% |
| Norfolk Southern Corp | Industrials | 1.6% |
| Accenture PLC | Information Technology | 1.6% |
| Eli Lilly & Co | Health Care | 1.6% |
| Alexandria Real Estate Equities Inc | Real Estate | 1.5% |
| Comcast Corp | Communication Services | 1.4% |
| Ally Financial Inc | Financials | 1.4% |
| Coca-Cola Co/The | Consumer Staples | 1.4% |
| Target Corp | Consumer Discretionary | 1.4% |
| Williams-Sonoma Inc | Consumer Discretionary | 1.3% |
| CIT Group Inc | Financials | 1.3% |
| Agilent Technologies Inc | Health Care | 1.3% |
| Abbott Laboratories | Health Care | 1.2% |
| Air Products and Chemicals Inc | Materials | 1.2% |
| Lam Research Corp | Information Technology | 1.2% |
| Hilton Worldwide Holdings Inc | Consumer Discretionary | 1.1% |
| Illinois Tool Works Inc | Industrials | 1.0% |
| Valvoline Inc | Materials | 1.0% |
| Procter & Gamble Co/The | Consumer Staples | 1.0% |
| Cheniere Energy Inc | Energy | 0.9% |
| Airbus SE | Industrials | 0.9% |
| Parker-Hannifin Corp | Industrials | 0.8% |
| Reliance Steel & Aluminum Co | Materials | 0.8% |
| Trane Technologies PLC | Industrials | 0.8% |
| Walmart Inc | Consumer Staples | 0.8% |
| Discover Financial Services | Financials | 0.8% |
| Starbucks Corp | Consumer Discretionary | 0.8% |
| Chubb Ltd | Financials | 0.7% |
| Sysco Corp | Consumer Staples | 0.6% |
| Dollar General Corp | Consumer Discretionary | 0.6% |
| LVMH Moet Hennessy Louis Vuitton SE | Consumer Discretionary | 0.5% |
| Analog Devices Inc | Information Technology | 0.5% |
| Crown Castle International Corp | Real Estate | 0.5% |
| Ecolab Inc | Materials | 0.5% |
| Citizens Financial Group Inc | Financials | 0.5% |
| Starwood Property Trust Inc | Real Estate | 0.4% |
| Medtronic PLC | Health Care | 0.4% |
| Samsung Electronics Co Ltd | Information Technology | 0.3% |
| S&P500 EMINI FUT DEC21 | Undefined | 0.0% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 12/31/2021
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
1.3%
|
|
| Real Estate |
 0.7%
|
|
| Utilities |
0.4%
|
|
| Consumer Discretionary |
1.2%
|
|
| Consumer Staples |
0.9%
|
|
| Energy |
0.3%
|
|
| Financials |
1.8%
|
|
| Health Care |
2.5%
|
|
| Industrials |
0.3%
|
|
| Information Technology |
0.8%
|
|
| Materials |
0.9%
|
PORTFOLIO DETAILS as of 12/31/2021
- Total Net Assets
- $6.68 B
- Number of Holdings
- 65
- Weighted Average Market Cap.
- 261.8 B
- P/B Ratio
- 3.6x
- P/E Ratio
- 19.7x
To view definitions for the above Portfolio Details, Click here.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Portfolio Turnover - This is a measure of the Fund’s trading activity which is computed by taking the lesser of purchases or sales divided by average monthly market value, excluding short-term investments. The resulting percentage represents the percentage of the portfolio’s holdings that have changed over the past year.
Contributors & Detractors as of 12/31/2021
Contributors
| Holding | Contribution |
|---|---|
| UnitedHealth Group, Inc. | 0.8% |
| AbbVie, Inc. | 0.7% |
| Pfizer, Inc. | 0.7% |
| Microsoft Corp. | 0.6% |
| Prologis Inc | 0.6% |
Detractors
| Holding | Contribution |
|---|---|
| Comcast Corp. | -0.2% |
| Medtronic PLC | -0.1% |
| Discover Financial Services | -0.1% |
| Casella Waste Systems, Inc. | -0.1% |
| Target Corp. | -0.1% |
% Contribution reflects the effect of the individual stock's performance on the Fund's overall performance for the period. Individual holdings and their effect on Fund performance may change significantly over time. Investors should consider the overall performance of the Fund before making a decision on whether or not to invest in the Fund.
Attribution Analysis
| Affiliated Fund | Benchmark | Variance | |||||
|---|---|---|---|---|---|---|---|
| Sector | Avg. Weight | Base Return | Avg. Weight | Base Return | Stock Selection | Group Weight | Total |
The total base return displayed for the Fund does not capture daily cash flow and trading activity and therefore is subject to reasonable variance from the Fund's actual return. Please refer to Lord Abbett Affiliated Fund Performance Results for the Fund's longer-term returns. The Fund is actively managed and portfolio characteristics, such as individual holdings and sector weightings, may change significantly over time.
Source: Wilshire Attribution Software. GICS sector classification; non-GICS securities classified by Lord Abbett. Sectors may include many industries.
Source: Wilshire Attribution Software. GICS sector classification; non-GICS securities classified by Lord Abbett. Sectors may include many industries.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 01/21/2022
- $0
- Dividend Frequency
- Quarterly
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 12/28/2021 | 12/29/2021 | 12/29/2021 | $0.09240 | $18.75 |
| 09/28/2021 | 09/29/2021 | 09/29/2021 | $0.08670 | $17.74 |
| 06/28/2021 | 06/29/2021 | 06/29/2021 | $0.07250 | $17.49 |
| 03/29/2021 | 03/30/2021 | 03/30/2021 | $0.06290 | $16.72 |
Upcoming Dividend Payment Dates
This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 03/29/2022 | 03/30/2022 | 03/30/2022 |
| 06/28/2022 | 06/29/2022 | 06/29/2022 |
| 09/28/2022 | 09/29/2022 | 09/29/2022 |
| 12/27/2022 | 12/28/2022 | 12/28/2022 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/22/2021 | 11/23/2021 | $0.4534 | - | $0.4534 | $18.54 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Upcoming Capital Gain Distribution
This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date |
|---|---|
| 11/21/2022 | 11/22/2022 |
Fees & Expenses
Fees & Expenses
Fund Documents
Fund Documents
Download fund documents & literature, create email subscriptions, and place direct mail order
|
0Documents selected
|
Order | ||||
|---|---|---|---|---|---|
| n/a |
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
| n/a |
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
|
Summary Prospectus
Publish Date:11/03/2015
|
|||||
| n/a |
Statutory Prospectus
Publish Date:11/03/2015
|
||||
| n/a |
Prospectus (XBRL)
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
|||||
|
Annual Report
Publish Date:11/03/2015
|
|||||
|
Semi-Annual Report
Publish Date:11/03/2015
|
|||||
|
Fact Sheet
Publish Date:11/03/2015
|
|||||
|
Commentary
Publish Date:11/03/2015
|
|||||